CDMO Rentschler Biopharma is signalling its intent to cut down cell and gene therapy operations by shutting down its UK ...

If authorised, Vimkunya would be the first vaccine in the EU to protect adolescents aged 12 to 17 against Chikungunya.

Roche has reported a 7% increase in full-year 2024 sales at constant exchange rates (CER), reaching CHF 60.5bn ($66.9bn). The ...

The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...

The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various ...

During a Senate HELP Committee hearing, RFK Jr. stated that President Trump is dedicated to bringing drug manufacturing "back ...

Sanofi has announced an increase in net income from continuing operations for the fourth quarter (Q4) of 2024, reaching €880m ...

On 1 January 2025, important legal amendments relating to drug pricing in Germany included in the Medical Research Act came ...

The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.

The move is part of HUTCHMED’s strategy to concentrate on its core business of developing new therapies for immunological diseases and cancers. Credit: THICHA ...

Takeda has announced the appointment of Julie Kim as the successor to Christophe Weber, effective from June 2026.

The partnership involves the development of an ADC for the treatment of individuals with advanced small cell lung cancer. Credit: Jo Panuwat D/Shutterstock. Innovent Biologics and Roche have entered a ...